Showing 1-5 of 318 resources:
Navigating European PASS & HTA Requirements: Leveraging Data Automation for Post-Authorization Success
Register >> July 17, 2025 3PM CEST The European pharmaceutical landscape presents complex challenges in meeting Post-Authorization Safety Study (PASS) obligations and Health Technology Assessment (HTA) requirements. Successfully navigating these evolving regulations, especially with the implementation of the EU HTA Regulation, is crucial for sustained market access and demonstrating ongoing product value. Designed for pharmaceutical[…]
Understanding the link between GLP-1 therapies and suicidal ideation using real-world data
Read the full article >> The Evidence Base May 19, 2025 In large clinical trials, glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant effectiveness in improving glycemic control and reducing cardiovascular risk. However, recent concerns have arisen following reports suggesting a potential association between GLP-1 receptor agonists and increased risk of suicidal ideation (SI) and[…]
OM1’s PhenOM® Foundation AI Surpasses One Billion Years of Health History in Model Training
Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, a leading provider of AI-driven insights for life sciences and healthcare organizations, today announced a major milestone in the development of its groundbreaking PhenOM® Foundation Model. The model has now been trained on more than one billion years of patient health histories, representing the largest model of its[…]